Cigna to launch specialized GLP-1 pharmacy next month

Posted on by wpadmin
Two packages of 5 dosing pens each of a fictitious Semiglutin drug used for weight loss (antidiabetic medication or anti-obesity medication) on a blue transparent background. Fictitious package design

aprott/iStock via Getty Images

Cigna (NYSE:CI) on Friday announced plans to launch a new specialized GLP-1 pharmacy called ENGUIDE from next month, as the obesity drug class popularized by Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) becomes a key

Leave a Reply

Your email address will not be published. Required fields are marked *